Observational studyJournal of health, population, and nutrition2025
Associations of the Charlson comorbidity index with asthma and mortality (NHANES 2007-2018): a cross-sectional study.
Observational study in Journal of health, population, and nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundPatients with asthma often suffer from multiple comorbid conditions, which can exacerbate disease severity and elevate the risk of mortality. This study aims to investigate the relationship between the Charlson Comorbidity Index (CCI) and asthma, as well as their combined impact on mortality.
methodsThis is an observational cross-sectional study based on the NHANES database conducted from 2007 to 2018. The study included a total of 26,002 adult participants. Logistic regression was performed to assess the relationship between the CCI and asthma. Survival analysis, including Kaplan-Meier analysis and Cox regression, was conducted to investigate the combined effect of the CCI and asthma on all-cause mortality. Subgroup analyses were performed to confirm the reliability of the outcomes.
resultsAfter adjusting for sex, age, race, body mass index, and other relevant covariates, our analysis showed an association between CCI and asthma (OR, 1.120; 95% CI, 1.059-1.186). Moreover, a higher CCI score was closely associated with increased mortality risk (HR, 1.143; 95% CI, 1.109-1.179) after adjustment of confounding factors. The risk of mortality was substantially higher for individuals with both asthma and a CCI score of ≥ 2 compared to those with no asthma and a CCI score of 0 (HR, 1.853; 95% CI, 1.440-2.383). Subgroup analyses further confirmed the trend that higher CCI levels are associated with poorer survival outcomes across multiple subgroups.
conclusionThe study indicates an association between the CCI and the risk of asthma, as well as their combined impact on elevated all-cause mortality. Since a high CCI score is associated with an increased risk of asthma and mortality, further studies are warranted to explore the causal relationship between these factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.